Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up0.63% Nasdaq Up0.64%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
146.86 Up 1.44(0.99%) 1:11PM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Research ReportsGet Research Reports for:
Recent Reports
ReleasedContributorAuthorTitlePagesPrice
Apr 15, 2014ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49
Apr 15, 2014New Constructs, LLCN/AALXN: Due Diligence Review: Forensic Earnings and Valuation5$25
Apr 11, 2014Alpha Street ResearchHunter OrrALXN - Alexion Pharmaceuticals Inc - Upgraded to a Buy - Company Analysis and ASR Ranking Report9$24
Apr 11, 2014S&P Capital IQ – STARS ReportsN/AAlexion Pharmaceuticals11$126.50
Apr 10, 2014Ford Investor Services, Inc.N/AIndustry Value Graph: ALXN , AMGN , BIIB , GILD -- DRUGS3$34.50
Apr 10, 2014Ford Investor Services, Inc.N/AValue Graph: ALEXION PHARM -- ALXN1$11.50
Apr 10, 2014Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ALEXION PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20
Apr 9, 2014ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for ALXN11$25
Apr 5, 2014TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ALEXION PHARMACEUTICALS INC (ALXN)5$10
Mar 29, 2014Wright ReportsN/AWright Investors Service Comprehensive Report for Alexion Pharmaceuticals, Inc.42$75

View All Reports for ALXN ...